Literature DB >> 8671614

alpha 4 integrin plays a critical role in early stages of T lymphocyte migration in Peyer's patches of rats.

Y Tsuzuki1, S Miura, M Suematsu, I Kurose, T Shigematsu, H Kimura, H Higuchi, H Serizawa, H Yagita, K Okumura, H Ishil.   

Abstract

Lymphocyte recirculation through the blood flow circuit and lymphoid organs is important for the maintenance of immune defense, and is defined as lymphocyte homing. During the homing process, several adhesion molecules have been postulated to play an important role in lymphocyte recruitment from the vascular space. In the present study, we investigated the effect of a novel mAb against rat alpha 4 integrin (MR alpha 4-1) on the interaction of T lymphocytes with postcapillary venules (PCV) and their subsequent migration into the interstitium of Peyer's patches, using intravital video microscopy. T lymphocytes collected from intestinal lymph were labeled with a fluorochrome carboxyfluorescein diacetate succinimidyl ester and were than injected into the jugular vein of recipient rats. The microvasculature in the ileal Peyer's patches of recipient rats was observed sequentially by intravital fluorescence microscopy. In controls, lymphocytes exhibited rolling behavior which was followed by firm adhesion to the endothelium of PCV. The density of sticking lymphocytes gradually increased during the first 30 min. These initial interactions of lymphocytes with the PCV (rolling and adherence) were drastically inhibited by treatment with MR alpha 4-1, both when MR alpha 4-1 was preinfused into rats and when T cells were preincubated in vitro with MR alpha 4-1 before administration. MR alpha 4-1 also significantly inhibited the transendothelial migration of T lymphocytes, associated by the ratio of migration to adherence. However, once T lymphocytes migrated into the interstitium, treatment with MR alpha 4-1 did not affect the pattern of travel of these lymphocytes in the interstitium or their transport into the microlymphatics in the parafollicular area. Therefore, we conclude that alpha 4 integrins play a critical role in the rolling and sticking of T cells and their transendothelial migration in PCV of Peyer's patches.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671614     DOI: 10.1093/intimm/8.3.287

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

Review 1.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis.

Authors:  Christina Ha; Asher Kornbluth
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

Review 3.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit.

Authors:  Charles G Lo; Ying Xu; Richard L Proia; Jason G Cyster
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

5.  Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration.

Authors:  Helen M McGettrick; Kirsty Hunter; Paul A Moss; Christopher D Buckley; G Ed Rainger; Gerard B Nash
Journal:  J Leukoc Biol       Date:  2008-10-23       Impact factor: 4.962

6.  Analysis of the effects of stromal cells on the migration of lymphocytes into and through inflamed tissue using 3-D culture models.

Authors:  Hannah C Jeffery; Christopher D Buckley; Paul Moss; G Ed Rainger; Gerard B Nash; Helen M McGettrick
Journal:  J Immunol Methods       Date:  2013-10-16       Impact factor: 2.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.